September 16, 2014

Movantik approved for constipation from opioids

(HealthDay)—Movantik (naloxegol) has been approved by the U.S. Food and Drug Administration to treat opioid-induced constipation, the agency said Tuesday.

Opioids are that commonly cause constipation. Movantik's safety and effectiveness to treat the problem were evaluated in two clinical studies involving 1,352 people who had taken opioids for at least four weeks for non-cancer related pain.

The most common side effects of Movantik were , diarrhea, headache and excessive gas, the FDA said in a news release.

Manufacturer AstraZeneca will be required to do an additional study to further evaluate the drug's cardiovascular safety, the agency added.

AstraZeneca is based in Wilmington, Del.

More information: Visit the FDA to learn more.

Copyright © 2014 HealthDay. All rights reserved.

Citation: Movantik approved for constipation from opioids (2014, September 16) retrieved 25 April 2024 from https://medicalxpress.com/news/2014-09-movantik-constipation-opioids.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Promising medication counteracts constipation caused by opioid painkillers
 shares

Feedback to editors
Living at higher altitudes in India linked to increased risk of childhood stunting

2 hours ago
Study confirms effectiveness of bivalent COVID-19 vaccine

4 hours ago
How does aging start? Scientists explain how IgG antibodies are a driving factor

4 hours ago
Study reveals emotional turmoil experienced after dog-theft is like that of a caregiver losing a child

4 hours ago
Targeting specific protein regions offers a new treatment approach in medulloblastoma

5 hours ago
Study recommends exposing deaf children to sign language before and after cochlear implantation

5 hours ago
Study reveals racial disparities in COVID-19 testing delays among health care workers

6 hours ago
Study reports new compound that halts replication of COVID by targeting 'Mac-1' protein in cell models

6 hours ago
Shoulder surgeons should rethink a common practice, new study suggests

6 hours ago
Study finds vitamin D alters mouse gut bacteria to give better cancer immunity

7 hours ago
Load comments (0)